Value of neutrophil/lymphocyte ratio in the diagnosis of diabetic neuropathy

Basit Öğe Kaydı
dc.authoridŞahin, Erkan Melih/0000-0003-1520-8464
dc.contributor.authorOcak, Ozgul
dc.contributor.authorŞahin, Erkan Melih
dc.date.accessioned2025-01-27T20:47:27Z
dc.date.available2025-01-27T20:47:27Z
dc.date.issued2023
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBackground Peripheral diabetic neuropathy (PDN) had been demonstrated as a chronic inflammation state and one of the most common complications of type 2 diabetes mellitus (T2DM). Neutrophil-to-lymphocyte ratio (NLR) is a novel marker to reflect many kinds of chronic inflammation disease including diabetes. We aim to evaluate the association between NLR and PDN and to determine whether NLR could be a new indicator of PDN in T2DM. Methods Hospital records of the patients who underwent electroneuromyography studies with the diagnosis of T2DM in the Neurology Outpatient Clinic between 01/01/2018 and 01/04/2021 were divided into two groups as those with normal results and those with polyneuropathy. The NLR was calculated from the hemogram tests. Results Eighty-nine (52.7%) normal and 80 (47.3%) PDN patients included in the study, of them 77 (45.6%) were male and 92 (54.4%) were female. The mean age of the patients was 58.92 +/- 13.88 years. According to the records examined, the mean NLR value was significantly higher in patients with PDN (2.70 +/- 1.99) than in those with normal results (1.98 +/- 0.80). According to the ROC analysis, the sensitivity is 0.875 and the specificity is 0.292 for 1.46, which is determined as the optimal cut-off value for the NLR value in the diagnosis of PDN. Conclusion The results of our study have shown that there was a significant correlation between NLR and PDN, implying that inflammation and endothelial dysfunction could be an integral part of PDN. NLR was significantly and independently raised in patients with T2DM.
dc.identifier.doi10.1007/s13410-022-01103-1
dc.identifier.endpage376
dc.identifier.issn0973-3930
dc.identifier.issn1998-3832
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85133626559
dc.identifier.scopusqualityQ3
dc.identifier.startpage371
dc.identifier.urihttps://doi.org/10.1007/s13410-022-01103-1
dc.identifier.urihttps://hdl.handle.net/20.500.12428/24908
dc.identifier.volume43
dc.identifier.wosWOS:000824924500003
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSpringer India
dc.relation.ispartofInternational Journal of Diabetes in Developing Countries
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectDiabetes
dc.subjectPeripheral diabetic neuropathy
dc.subjectNeutrophil-to-lymphocyte ratio
dc.subjectROC analysis
dc.titleValue of neutrophil/lymphocyte ratio in the diagnosis of diabetic neuropathy
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu